Sign in

You're signed outSign in or to get full access.

LF

Lowell Farms Inc. (LOWLF)·Q2 2024 Earnings Summary

Executive Summary

  • Net revenue declined to $3.54M, down 27% sequentially and 50% YoY, primarily due to exiting cultivation; gross margin improved modestly to -15.7% from -17.0% in Q1 but remained negative .
  • Operating loss narrowed to $2.2M vs $2.9M in Q1; net loss was $0.8M aided by ~$2.3M other income from reversal of a cultivation lease accrual following a judicial ruling; adjusted EBITDA deteriorated to -$1.9M (vs -$1.1M Q1) .
  • CPG revenue fell 15% QoQ; bulk product revenue collapsed to $0.05M as cultivation exit took full effect; owned brands were $2.6M vs $3.1M in Q1; third‑party brands revenue was $0.78M vs $0.95M in Q1 .
  • No formal revenue/margin guidance provided; a strategic alternatives process and service expansion to leverage assets, reduce overhead, and strengthen the financial position were highlighted as near‑term catalysts .
  • S&P Global consensus estimates unavailable for LOWLF; comparisons to Street estimates could not be made (S&P Global data unavailable via CIQ mapping).

What Went Well and What Went Wrong

What Went Well

  • Gross margin improved modestly to -15.7% from -17.0% in Q1, reflecting progress absorbing impacts from the cultivation exit .
  • Operating loss narrowed to $2.2M vs $2.9M in Q1, supported by cost controls and other income tied to lease accrual reversal after a judicial ruling (~$2.3M) .
  • Management articulated a focused plan: “By expanding our services, we aim to better leverage our existing assets, reduce operational overhead, and strengthen our financial position” (CEO Mark Ainsworth) .

What Went Wrong

  • Net revenue decreased 27% QoQ to $3.54M and 50% YoY due to the full‑quarter impact of cultivation exit and weaker California purchasing trends/flower price instability .
  • Adjusted EBITDA worsened to -$1.9M from -$1.1M in Q1; CPG revenue fell 15% QoQ and average delivery drop value decreased to $3,735 from $4,082, indicating softer sell‑through .
  • Bulk product revenue collapsed to $0.05M (from $0.68M in Q1 and $2.26M in Q2’23), highlighting the discontinuity from ceasing cultivation .

Financial Results

Consolidated Performance vs Prior Periods and YoY

MetricQ2 2023Q4 2023Q1 2024Q2 2024
Revenue ($USD Millions)$7.032 $7.495 $4.874 $3.538
Gross Margin %n/an/a-17.0% -15.7%
Operating Loss ($USD Millions)$2.7 n/a$2.9 $2.2
Net Loss ($USD Millions)$0.1 n/a$2.9 $0.8
EPS (Basic, $USD)$(0.01) n/a$(0.15) $(0.04)
Adjusted EBITDA ($USD Millions)$(1.3) $(4.1) $(1.1) $(1.9)

Note: “n/a” where quarterly detail not disclosed in the cited documents.

Segment Revenue Breakdown

Segment ($USD Millions)Q2 2023Q1 2024Q2 2024
CPG Revenues$4.438 $4.125 $3.489
Bulk Product$2.263 $0.681 $0.049
LFS$0.094 $0.068 $0.000
Out‑of‑State Licensing$0.237 $0.000 $0.000
Total$7.032 $4.874 $3.538

KPIs and Operational Metrics

KPIQ1 2024Q2 2024Trend
Owned Brands Revenue ($USD Millions)$3.1 $2.6 Down QoQ
Lowell Herb Co 35’s ($USD Thousands)$919 $682 Down QoQ
Infused 35’s ($USD Thousands)$170 $147 Down QoQ
Third‑Party Brands Revenue ($USD Thousands)$952 $778 Down QoQ
Avg Delivery Drop Value ($USD)$4,082 $3,735 Down QoQ
LFS Processed Wet Weight (lbs)6,173 1,855 Down QoQ

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueFY/QuarterNone provided None provided Maintained (no guidance)
Gross MarginFY/QuarterNone provided None provided Maintained (no guidance)
OpExFY/QuarterNone provided None provided Maintained (no guidance)
Other (OI&E/Tax/Dividends)FY/QuarterNone provided None provided Maintained (no guidance)

Management emphasized strategic alternatives and service expansion to leverage assets and reduce overhead but did not issue quantitative guidance ranges .

Earnings Call Themes & Trends

Transcript was not available in our document system; the company announced call logistics, but a full transcript could not be retrieved; we searched both internal documents and the internet for a full transcript without success .

TopicPrevious Mentions (Q4 2023)Previous Mentions (Q1 2024)Current Period (Q2 2024)Trend
Strategic restructuring/alternatives“Restructured company” positioning for improvement “Strategic shifts… expect meaningful change” Exploring strategic alternatives; expand services to leverage assets, reduce overhead Continued execution
Cultivation exit impactImpairments, lease transactions; termination of cultivation lease (Jan 2024) Cultivation exit drove lower LFS volumes; bulk revenue down Full impact: bulk product revenue collapsed; LFS processed volume down Headwind realized
California market demand/pricingNoted instability and demand challenges Purchasing trends weak; price instability Continued weakness; owned brands down QoQ Persistent pressure
Third‑party brand strategyRe‑engaged model; 16 brands added; placements in 650 dispensaries ~20 additional brands by Q1 Added three more brands in Q2; revenue down QoQ Scaling mix; softer revenue
Distribution efficiencyAvg drop value fell YoY to $3,809 in Q4 Improved to $4,082 Decreased to $3,735 Volatile
Legal/regulatoryJudicial ruling driven rent accrual reversal boosting other income (~$2.3M) One‑time tailwind
LeadershipAppointed CFO (Feb) CFO resigned; CEO became Interim CFO (June 28) Transition

Management Commentary

  • “By expanding our services, we aim to better leverage our existing assets, reduce operational overhead, and strengthen our financial position” — Mark Ainsworth, CEO .
  • “Our strategic decisions have now positioned us favorably and we expect to see a positive impact on the company in the quarters ahead” — Mark Ainsworth (Q4 2023 release) .
  • “Our recent strategic decisions have thoughtfully bolstered our manufacturing and distribution capabilities… we’re poised for steady growth and positive impact” — Mark Ainsworth (Q1 2024 release) .
  • On leadership: Thanks extended to outgoing CFO; CEO now serving as Interim CFO .

Q&A Highlights

A full earnings call transcript was not available in the document system; we searched for a transcript internally and externally but could not retrieve the full Q&A. Therefore, specific analyst questions, guidance clarifications, and tone shifts cannot be summarized at this time .

Estimates Context

  • S&P Global consensus estimates for Q2 2024 (EPS, revenue, EBITDA) were unavailable for LOWLF due to missing Capital IQ mapping; as a result, we cannot provide a results‑vs‑consensus comparison (S&P Global data unavailable via CIQ mapping).
  • Implication: Sell‑side may be limited or non‑existent; investors should focus on sequential/YoY trends and management’s qualitative framework pending availability of formal coverage.

Key Takeaways for Investors

  • Revenue trajectory remains under pressure as the cultivation exit fully impacts bulk sales; focus shifts to CPG and third‑party brand distribution as primary revenue drivers .
  • Margins are improving modestly but remain negative; further cost actions and service expansion are needed to reach breakeven .
  • Adjusted EBITDA deterioration QoQ underscores near‑term profitability challenges despite narrower operating loss; one‑time other income aided net loss optics .
  • Owned brands and third‑party brands both declined QoQ; average delivery drop value deterioration signals soft retail sell‑through in California .
  • Leadership transition (Interim CFO) and active strategic alternatives review suggest potential corporate actions; monitor catalysts from service expansion and any strategic transactions .
  • Liquidity compressed with cash at $0.64M at quarter‑end; working capital down sharply vs year‑end, elevating execution and financing risk .
  • Near‑term trading: stock likely sensitive to updates on strategic alternatives, service revenue scaling, and any evidence of margin stabilization; medium‑term thesis depends on CPG growth, distribution efficiency, and cost discipline in the post‑cultivation model .

Appendix: Additional Financial Detail

Balance Sheet Snapshot

Metric ($USD Millions)Dec 31, 2023Jun 30, 2024
Cash & Cash Equivalents$2.311 $0.642
Accounts Receivable (net)$2.620 $1.844
Inventory$4.760 $2.926
Total Current Assets$12.088 $7.050
Total Liabilities$26.135 $23.125
Total Stockholders’ Equity$11.478 $7.827

Cash Flow (Six Months Ended)

Metric ($USD Millions)6M 20236M 2024
Net Cash from Operating Activities$(0.423) $(1.557)
Net Cash from Investing Activities$(0.019) $0.000
Net Cash from Financing Activities$7.766 $(0.112)
Ending Cash Balance$8.422 $0.642